Peer Review reports
From: Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis
| Original Submission | ||
|---|---|---|
| 24 Mar 2023 | Submitted | Original manuscript |
| 9 Jun 2023 | Reviewed | Reviewer Report |
| 28 Jul 2023 | Reviewed | Reviewer Report |
| 1 Aug 2023 | Reviewed | Reviewer Report |
| 20 Aug 2023 | Author responded | Author comments - Tangfeng Lv |
| 21 Aug 2023 | Reviewed | Reviewer Report |
| 8 Sep 2023 | Reviewed | Reviewer Report |
| 7 Oct 2023 | Author responded | Author comments - Tangfeng Lv |
| Resubmission - Version 2 | ||
| 20 Aug 2023 | Submitted | Manuscript version 2 |
| 11 Oct 2023 | Author responded | Author comments - Tangfeng Lv |
| Resubmission - Version 3 | ||
| 11 Oct 2023 | Submitted | Manuscript version 3 |
| Publishing | ||
| 25 Oct 2023 | Editorially accepted | |
| 21 Feb 2024 | Article published | 10.1186/s12879-023-08754-3 |
You can find further information about peer review here.